US Stock MarketDetailed Quotes

OMGA Omega Therapeutics

Watchlist
  • 0.796
  • -0.001-0.08%
Close Nov 27 16:00 ET
  • 0.820
  • +0.024+3.04%
Post 20:01 ET
44.06MMarket Cap-602P/E (TTM)

Omega Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
214.32%2.61M
181.16%2.13M
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
Operating revenue
214.32%2.61M
181.16%2.13M
357.36%2.36M
49.25%3.09M
34.56%989K
39.66%831K
59.45%759K
92.54%516K
1,339.58%2.07M
410.42%735K
Cost of revenue
Gross profit
Operating expense
-19.81%19.03M
-40.78%18.71M
-13.38%22.81M
-1.42%103.36M
-31.59%21.69M
-10.71%23.73M
20.01%31.6M
30.19%26.33M
58.42%104.84M
52.35%31.7M
Selling and administrative expenses
-13.88%6.23M
-11.94%5.77M
18.47%7.4M
10.62%26.19M
-14.56%6.16M
39.05%7.23M
5.72%6.56M
15.48%6.24M
42.58%23.67M
26.60%7.21M
-General and administrative expense
-13.88%6.23M
-11.94%5.77M
18.47%7.4M
10.62%26.19M
-14.56%6.16M
39.05%7.23M
5.72%6.56M
15.48%6.24M
42.58%23.67M
26.60%7.21M
Research and development costs
-22.41%12.81M
-48.33%12.94M
-23.27%15.42M
-4.93%77.17M
-42.13%15.53M
-20.15%16.51M
29.17%25.04M
41.58%20.09M
69.57%81.17M
83.28%26.84M
Operating profit
28.31%-16.42M
46.24%-16.58M
20.79%-20.45M
2.44%-100.26M
33.16%-20.7M
11.86%-22.9M
-19.29%-30.84M
-29.36%-25.82M
-55.63%-102.77M
-49.86%-30.97M
Net non-operating interest income expense
-97.95%14K
-68.76%299K
-51.47%331K
1,165.77%2.81M
96.37%487K
271.74%684K
1,840.00%957K
540.00%682K
124.40%222K
246.75%248K
Non-operating interest income
----
-68.76%299K
-51.47%331K
1,165.77%2.81M
----
----
--957K
--682K
--222K
----
Total other finance cost
97.95%-14K
----
----
----
----
-271.74%-684K
----
----
----
----
Other net income (expense)
-31.03%-38K
-112.24%-24K
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
88.27%-157K
-409.52%-107K
Other non- operating income (expenses)
-31.03%-38K
-112.24%-24K
93.71%-9K
114.65%23K
98.13%-2K
-1,550.00%-29K
6,633.33%196K
-186.00%-143K
-460.71%-157K
-409.52%-107K
Income before tax
26.09%-16.44M
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
Income tax
Net income
26.09%-16.44M
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
Net income continuous Operations
26.09%-16.44M
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
Minority interest income
Net income attributable to the parent company
26.09%-16.44M
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
26.09%-16.44M
45.08%-16.31M
20.37%-20.13M
5.13%-97.43M
34.43%-20.21M
13.76%-22.25M
-14.57%-29.69M
-25.37%-25.28M
-50.41%-102.7M
-47.82%-30.83M
Basic earnings per share
25.00%-0.3
44.44%-0.3
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
Diluted earnings per share
25.00%-0.3
44.44%-0.3
28.00%-0.36
15.89%-1.8
43.75%-0.36
25.93%-0.4
0.00%-0.54
-19.05%-0.5
29.84%-2.14
-45.45%-0.64
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 214.32%2.61M181.16%2.13M357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K
Operating revenue 214.32%2.61M181.16%2.13M357.36%2.36M49.25%3.09M34.56%989K39.66%831K59.45%759K92.54%516K1,339.58%2.07M410.42%735K
Cost of revenue
Gross profit
Operating expense -19.81%19.03M-40.78%18.71M-13.38%22.81M-1.42%103.36M-31.59%21.69M-10.71%23.73M20.01%31.6M30.19%26.33M58.42%104.84M52.35%31.7M
Selling and administrative expenses -13.88%6.23M-11.94%5.77M18.47%7.4M10.62%26.19M-14.56%6.16M39.05%7.23M5.72%6.56M15.48%6.24M42.58%23.67M26.60%7.21M
-General and administrative expense -13.88%6.23M-11.94%5.77M18.47%7.4M10.62%26.19M-14.56%6.16M39.05%7.23M5.72%6.56M15.48%6.24M42.58%23.67M26.60%7.21M
Research and development costs -22.41%12.81M-48.33%12.94M-23.27%15.42M-4.93%77.17M-42.13%15.53M-20.15%16.51M29.17%25.04M41.58%20.09M69.57%81.17M83.28%26.84M
Operating profit 28.31%-16.42M46.24%-16.58M20.79%-20.45M2.44%-100.26M33.16%-20.7M11.86%-22.9M-19.29%-30.84M-29.36%-25.82M-55.63%-102.77M-49.86%-30.97M
Net non-operating interest income expense -97.95%14K-68.76%299K-51.47%331K1,165.77%2.81M96.37%487K271.74%684K1,840.00%957K540.00%682K124.40%222K246.75%248K
Non-operating interest income -----68.76%299K-51.47%331K1,165.77%2.81M----------957K--682K--222K----
Total other finance cost 97.95%-14K-----------------271.74%-684K----------------
Other net income (expense) -31.03%-38K-112.24%-24K93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K88.27%-157K-409.52%-107K
Other non- operating income (expenses) -31.03%-38K-112.24%-24K93.71%-9K114.65%23K98.13%-2K-1,550.00%-29K6,633.33%196K-186.00%-143K-460.71%-157K-409.52%-107K
Income before tax 26.09%-16.44M45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M
Income tax
Net income 26.09%-16.44M45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M
Net income continuous Operations 26.09%-16.44M45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M
Minority interest income
Net income attributable to the parent company 26.09%-16.44M45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 26.09%-16.44M45.08%-16.31M20.37%-20.13M5.13%-97.43M34.43%-20.21M13.76%-22.25M-14.57%-29.69M-25.37%-25.28M-50.41%-102.7M-47.82%-30.83M
Basic earnings per share 25.00%-0.344.44%-0.328.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.64
Diluted earnings per share 25.00%-0.344.44%-0.328.00%-0.3615.89%-1.843.75%-0.3625.93%-0.40.00%-0.54-19.05%-0.529.84%-2.14-45.45%-0.64
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data